| Dr Polina Inkoulova, MD | |
|
801 Central Ave Ste 1, Dover, NH 03820-2529 | |
| (603) 740-9713 | |
| (603) 740-2447 |
| Full Name | Dr Polina Inkoulova |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 31 Years |
| Location | 801 Central Ave Ste 1, Dover, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801095906 | NPI | - | NPPES |
| 3095935 | Medicaid | NH |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi Health St. Francis | Grand island, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wentworth Douglass Physician Corporation | 5496749848 | 372 |
| Chi Health Clinic Specialty Llc | 4789098443 | 234 |
News Archive
Up to 80 percent of patients who have surgery complain of nausea and vomiting afterwards, but stimulating an acupoint in their wrists can help reduce these symptoms, finds a new evidence review.
Some women take a short break from using postmenopausal hormone therapy before getting their breasts screened for cancer with mammography. They hope to lower their risk of being called back afterward for unnecessary extra breast imaging. But taking a short break from hormones doesn't actually work for this purpose, according to the first large-scale randomized controlled trial to address the question. The READ (Radiological Evaluation and Breast Density) trial of more than 1,700 Group Health women is in the June 2, 2009 Annals of Internal Medicine.
Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today that the company has reached agreements with the FDA and EMA regarding the Phase III study design outline of NiCord.
Access Intelligence LLC and its Dorland Health division announced today the acquisition of OR Manager, the premier media brand and annual educational conference and trade show for operating room executives, managers and hospital directors. This acquisition represents Access Intelligence's growing role in the healthcare management industry within four niche markets: medical coding, case management, patient advocacy and operating room management.
For every year that a patient with diabetes takes metformin, their risk for hepatocellular carcinoma reduces, say the authors of a study that also sheds light on the cellular pathway it uses.
› Verified 9 days ago
| Entity Name | Wentworth Douglass Physician Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447352430 PECOS PAC ID: 5496749848 Enrollment ID: O20040409000433 |
News Archive
Up to 80 percent of patients who have surgery complain of nausea and vomiting afterwards, but stimulating an acupoint in their wrists can help reduce these symptoms, finds a new evidence review.
Some women take a short break from using postmenopausal hormone therapy before getting their breasts screened for cancer with mammography. They hope to lower their risk of being called back afterward for unnecessary extra breast imaging. But taking a short break from hormones doesn't actually work for this purpose, according to the first large-scale randomized controlled trial to address the question. The READ (Radiological Evaluation and Breast Density) trial of more than 1,700 Group Health women is in the June 2, 2009 Annals of Internal Medicine.
Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today that the company has reached agreements with the FDA and EMA regarding the Phase III study design outline of NiCord.
Access Intelligence LLC and its Dorland Health division announced today the acquisition of OR Manager, the premier media brand and annual educational conference and trade show for operating room executives, managers and hospital directors. This acquisition represents Access Intelligence's growing role in the healthcare management industry within four niche markets: medical coding, case management, patient advocacy and operating room management.
For every year that a patient with diabetes takes metformin, their risk for hepatocellular carcinoma reduces, say the authors of a study that also sheds light on the cellular pathway it uses.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Polina Inkoulova, MD 789 Central Ave, Dover, NH 03820-2589 Ph: (603) 609-6925 | Dr Polina Inkoulova, MD 801 Central Ave Ste 1, Dover, NH 03820-2529 Ph: (603) 740-9713 |
News Archive
Up to 80 percent of patients who have surgery complain of nausea and vomiting afterwards, but stimulating an acupoint in their wrists can help reduce these symptoms, finds a new evidence review.
Some women take a short break from using postmenopausal hormone therapy before getting their breasts screened for cancer with mammography. They hope to lower their risk of being called back afterward for unnecessary extra breast imaging. But taking a short break from hormones doesn't actually work for this purpose, according to the first large-scale randomized controlled trial to address the question. The READ (Radiological Evaluation and Breast Density) trial of more than 1,700 Group Health women is in the June 2, 2009 Annals of Internal Medicine.
Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today that the company has reached agreements with the FDA and EMA regarding the Phase III study design outline of NiCord.
Access Intelligence LLC and its Dorland Health division announced today the acquisition of OR Manager, the premier media brand and annual educational conference and trade show for operating room executives, managers and hospital directors. This acquisition represents Access Intelligence's growing role in the healthcare management industry within four niche markets: medical coding, case management, patient advocacy and operating room management.
For every year that a patient with diabetes takes metformin, their risk for hepatocellular carcinoma reduces, say the authors of a study that also sheds light on the cellular pathway it uses.
› Verified 9 days ago
Dr. Mark Lee Dick, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Fl 5, Dover, NH 03820 Phone: 603-609-6800 | |
Mrs. Jhansi Lakshmi Maradana, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Ste 400, Dover, NH 03820 Phone: 603-742-1143 Fax: 603-749-3509 | |
Ravi Teja Pasam, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-740-2503 Fax: 603-740-2497 | |
Paul C Tung, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 10 Members Way, Suite 400, Dover, NH 03820 Phone: 603-742-1143 Fax: 603-749-3509 | |
Amy Claire Bessnow, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-740-2694 | |
Dylan Thomas, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Ste 400, Dover, NH 03820 Phone: 603-742-1143 Fax: 603-749-3509 | |
Alison M Sollee, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Fl 5, Dover, NH 03820 Phone: 603-609-6800 |